Characteristics of gut microbiota at colorectal cancer tissue, metastatic liver and lymph nodes tissue in colorectal cancer patients

  • Nguyễn Duy Trường Bệnh viện Trung ương Quân đội 108
  • Ngô Tất Trung Bệnh viện Trung ương Quân đội 108
  • Trần Thị Thanh Huyền Bệnh viện Trung ương Quân đội 108
  • Đào Thanh Quyên Bệnh viện Trung ương Quân đội 108
  • Đào Thị Huyền Bệnh viện Trung ương Quân đội 108
  • Phạm Quang Trung Bệnh viện Trung ương Quân đội 108
  • Lê Hữu Song Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

16S rRNA metagenomic, Colorectal cancer

Abstract

Objective: To describe gut microbiota composition and diversity at colorectal cancer (CRC) tissue, metastatic liver and lymph nodes tissue in CRC patients. Subject and method: 21 patients with CRC at stage IV treated at 108 Military Central Hospital from March 2015 to August 2018 were recruited into the current cross-sectional study. Clinical information and tissue samples (include 21 CRC tissue samples, 21 metastatic liver tissue samples and 11 metastatic lymph nodes tissue samples) were collected from the CRC patients. Sequencing of the 16S rRNA gene targeted V3-V4 region was used to access gut microbiota composition and diversity of the studied samples. Result: The phyla accounting for the highest proportion in the three types of tissue samples included Proteobacteria, Actinobacteriota, Firmicutes, Bacteroidota, Deinococcota, and Fusobacteriota. The alpha diversity in the CRC tissue samples was higher than in the  metastatic liver tissue samples (p<0.05). There was significant difference in beta diversity between the CRC tissue and the metastatic liver, and between the CRC tissue and the metastatic lymph nodes (p<0.05). Conclusion: Preliminary analysis determined the characteristics of gut microbiota at CRC tissue, metastatic liver and lymph nodes tissue using 16S rRNA metagenomics.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3): 209-249.
2. RA S (2018) Molecular Biology of Colorectal Cancer. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Vol. 11th edition ed, Philadelphia: Wolters Kluwer 1634-1651.
3. Azevedo MM, Pina-Vaz C, and Baltazar F (2020) Microbes and cancer: Friends or faux? Int J Mol Sci. 21(9).
4. Garrett WS (2015) Cancer and the microbiota. Science 348(6230): 80-86.
5. Peddareddigari VG, Wang D, and Dubois RN (2010) The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 3(1): 149-66.
6. Siegel RL, Miller KD, and Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1): 7-30.
7. Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, Meltser A, Douglas GM, Kamer I, Gopalakrishnan V, Dadosh T, Levin-Zaidman S, Avnet S, Atlan T, Cooper ZA, Arora R, Cogdill AP, Khan MAW, Ologun G, Bussi Y, Weinberger A, Lotan-Pompan M, Golani O, Perry G, Rokah M, Bahar-Shany K, Rozeman EA, Blank CU, Ronai A, Shaoul R, Amit A, Dorfman T, Kremer R, Cohen ZR, Harnof S, Siegal T, Yehuda-Shnaidman E, Gal-Yam EN, Shapira H, Baldini N, Langille MGI, Ben-Nun A, Kaufman B, Nissan A, Golan T, Dadiani M, Levanon K, Bar J, Yust-Katz S, Barshack I, Peeper DS, Raz DJ, Segal E, Wargo JA, Sandbank J, Shental N, Straussman R (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494): 973-980.
8. Emery DC, Cerajewska TL, Seong J, Davies M, Paterson A, Allen-Birt SJ, West NX (2020) Comparison of blood bacterial communities in periodontal health and periodontal disease. Front Cell Infect Microbiol 10: 577485.
9. Yuan J, Zhao J, Wen T, Zhao M, Li R, Goossens P, Huang Q, Bai Y, Vivanco JM, Kowalchuk GA, Berendsen RL, Shen Q (2018) Root exudates drive the soil-borne legacy of aboveground pathogen infection. Microbiome 6(1): 156.
10. Hall M and Beiko RG (2018) 16S rRNA Gene Analysis with QIIME2. Methods Mol Biol 1849: 113-129.
11. Edgar RC (2013) UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10(10): 996-998.
12. Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, Ng SC, Tsoi H, Dong Y, Zhang N, He Y, Kang Q, Cao L, Wang K, Zhang J, Liang Q, Yu J, Sung JJ (2015) Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 6: 8727.
13. Acar C, Celik SK, Ozdemirel HO, Tuncdemir BE, Alan S, Mergen H (2023) Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer. Folia Microbiol (Praha).
14. Shen X, Li J, Li J, Zhang Y, Li X, Cui Y, Gao Q, Chen X, Chen Y, Fang JY (2021) Fecal Enterotoxigenic Bacteroides fragilis-Peptostreptococcus stomatis-parvimonas micra biomarker for noninvasive diagnosis and prognosis of colorectal laterally spreading tumor. Front Oncol 11: 661048.
15. Bundgaard-Nielsen C, Baandrup UT, Nielsen LP, Sørensen S (2019) The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue. BMC Cancer 19(1): 399.
16. Zhou P, Dai Z, Xie Y, Li T, Xu Z, Huang Y, Sun D, Zhou Y (2023) Differences in tissue-associated bacteria between metastatic and non-metastatic colorectal cancer. Front Microbiol 14: 1133607.